Trials / Withdrawn
WithdrawnNCT01582828
Serial Hybrid Atrial Fibrillation Ablation
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Medisch Spectrum Twente · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Treatment of (long-standing) persistent atrial fibrillation (AF) remains cumbersome and the surgical (epicardial) approach seems to be the most effective. Still, however a significant amount of failures exist which is mostly due to incompleteness of the surgical ablation lines. Checking, and if necessary additional ablation, of these lines afterwards endocardially by the cardiologist (the so-called serial hybrid approach) could overcome this problem.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Epicardial (surgical) ablation | * Pulmonary vein isolation with bipolar clamps and bipolar box lesion * Epicardial atrial appendage closure |
| PROCEDURE | Hybrid | Epicardial (surgical) ablation * Pulmonary vein isolation with bipolar clamps and bipolar box lesion * Epicardial atrial appendage closure Endocardial assessment after 6-8 weeks, checking for isolation and if necessary touch up by RF ablation |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2016-12-01
- Completion
- 2017-12-01
- First posted
- 2012-04-23
- Last updated
- 2024-11-22
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01582828. Inclusion in this directory is not an endorsement.